ZOLL LifeVest
ZOLL Medical Corporation specializes in innovative medical devices and software solutions aimed at improving emergency and cardiac care. Their portfolio includes the LifeVest wearable defibrillator, Heart Failure Management System, TherOx oxygen therapy, and WatchPAT sleep apnea solutions, all designed to deliver better insights and outcomes in cardiac patient management.
Industries
Nr. of Employees
small (1-50)
ZOLL LifeVest
Pittsburgh, Pennsylvania, United States, North America
Products
Wearable cardioverter-defibrillator (ambulatory WCD)
A patient-worn device and garment system that continuously monitors ECG and delivers automatic defibrillation therapy for detected VT/VF events while capturing ECG and biometric data for clinical review.
Patch-based remote heart-failure monitoring system (radiofrequency sensor)
A water-resistant thoracic patch that transmits radiofrequency signals to detect changes in pulmonary/interstitial fluid (Thoracic Fluid Index) and records additional biometric signals (ECG, heart rate, respiration, activity, posture) for remote clinical monitoring.
Ambulatory cardiac monitors with enriched biometric reporting
Traditional mobile cardiac telemetry and next-generation monitoring systems that detect arrhythmias and provide event-based and end-of-use reports enhanced with biometric context (sleep, activity, respiratory rate, posture).
Supersaturated oxygen therapy (hospital/acute use)
A catheter-delivered supersaturated oxygen therapy intended to reduce myocardial damage and risk of heart-failure progression after acute ischemic injury.
Home sleep apnea testing using peripheral arterial tonometry
Home sleep apnea diagnostic testing based on peripheral arterial tonometry and related sensors for obstructive sleep apnea assessment.
Wearable cardioverter-defibrillator (ambulatory WCD)
A patient-worn device and garment system that continuously monitors ECG and delivers automatic defibrillation therapy for detected VT/VF events while capturing ECG and biometric data for clinical review.
Patch-based remote heart-failure monitoring system (radiofrequency sensor)
A water-resistant thoracic patch that transmits radiofrequency signals to detect changes in pulmonary/interstitial fluid (Thoracic Fluid Index) and records additional biometric signals (ECG, heart rate, respiration, activity, posture) for remote clinical monitoring.
Ambulatory cardiac monitors with enriched biometric reporting
Traditional mobile cardiac telemetry and next-generation monitoring systems that detect arrhythmias and provide event-based and end-of-use reports enhanced with biometric context (sleep, activity, respiratory rate, posture).
Supersaturated oxygen therapy (hospital/acute use)
A catheter-delivered supersaturated oxygen therapy intended to reduce myocardial damage and risk of heart-failure progression after acute ischemic injury.
Home sleep apnea testing using peripheral arterial tonometry
Home sleep apnea diagnostic testing based on peripheral arterial tonometry and related sensors for obstructive sleep apnea assessment.
Services
Continuous remote monitoring and analysis of device data by a certified diagnostic testing facility, with clinician notifications and structured reports.
Device shipment, patient setup assistance, educational videos and materials, and 24/7 multilingual support for enrolled patients.
Ordering, enrollment, and billing support for remote monitoring services through a provider network, with coding guidance for RPM reimbursement.
Participation in and support for randomized trials, prospective registries, multicenter studies, and publication of clinical outcomes to evaluate device effectiveness.
Continuous remote monitoring and analysis of device data by a certified diagnostic testing facility, with clinician notifications and structured reports.
Device shipment, patient setup assistance, educational videos and materials, and 24/7 multilingual support for enrolled patients.
Ordering, enrollment, and billing support for remote monitoring services through a provider network, with coding guidance for RPM reimbursement.
Participation in and support for randomized trials, prospective registries, multicenter studies, and publication of clinical outcomes to evaluate device effectiveness.
Expertise Areas
- Cardiac monitoring and wearable therapeutics
- Remote physiologic monitoring and telemetry
- Arrhythmia detection algorithms and AI-driven signal processing
- Clinical trial design, registries, and outcomes research
Key Technologies
- Automated wearable defibrillation systems
- AI-based ECG signal classification and noise reduction
- Radiofrequency thoracic fluid sensing (patch-based)
- Cellular-enabled remote monitoring gateways
News & Updates
A retrospective study of over 6,000 German patients evaluating the safety and efficacy of the WCD in the German healthcare system.
A long-term survival analysis of over 3,500 patients who wore the WCD, comparing it to first ICD implantation.
A prospective registry of 2,000 US patients assessing the safety and efficacy of the WCD in real-world settings.
A multicenter observational study of over 1,000 French patients evaluating WCD efficacy and patient experience.
A retrospective study of over 8,400 patients at high risk of SCD during the post-MI waiting period.
A 90-day survival analysis of nearly 5,000 post-PCI and post-CABG patients using the WCD.
A retrospective study of over 6,000 German patients evaluating the safety and efficacy of the WCD in the German healthcare system.
A long-term survival analysis of over 3,500 patients who wore the WCD, comparing it to first ICD implantation.
A prospective registry of 2,000 US patients assessing the safety and efficacy of the WCD in real-world settings.
A multicenter observational study of over 1,000 French patients evaluating WCD efficacy and patient experience.
A retrospective study of over 8,400 patients at high risk of SCD during the post-MI waiting period.
A 90-day survival analysis of nearly 5,000 post-PCI and post-CABG patients using the WCD.